Senate OKs big NIH bump

The US Senate, which is furiously debating the details of the economic stimulus package making its way through Congress, passed an amendment yesterday (Feb. 3) to add $6.5 billion in National Institutes of Health funding on top of the $3.5 billion already allotted to the agency in the bill. Science advocacy groups praised passage of the amendment, which was sponsored by Senators Arlen Specter (R-PA), Tom Harkin (D-IA) and Dick Durbin (D-IL). linkurl:Richard Marchase,;http://main.uab.edu/show.a

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The US Senate, which is furiously debating the details of the economic stimulus package making its way through Congress, passed an amendment yesterday (Feb. 3) to add $6.5 billion in National Institutes of Health funding on top of the $3.5 billion already allotted to the agency in the bill. Science advocacy groups praised passage of the amendment, which was sponsored by Senators Arlen Specter (R-PA), Tom Harkin (D-IA) and Dick Durbin (D-IL). linkurl:Richard Marchase,;http://main.uab.edu/show.asp?durki=8039 president of the Federation of American Societies for Experimental Biology (FASEB), said that the sponsors of the amendment were "champions of biomedical research," in a statement. "Millions of Americans who suffer from devastating illnesses like cancer and Alzheimer's disease, as well as the hundreds of thousands whose jobs depend on NIH funding, owe a great deal to these leaders," he added. "It is our hope that the economic recovery package is one step forward towards a long-term, sustainable investment in medical research." linkurl:John Morrison,;http://www.mountsinai.org/Find%20A%20Faculty/profile.do?id=0000072500001497270992 the chair of Society for Neuroscience's (SfN) government and public affairs committee, added his encouragement for the NIH budget bump. "SfN applauds the efforts of Sen. Arlen Specter (R-PA) and others to provide $10 billion for the National Institutes of Health in the economic recovery package, helping to save and create jobs now while investing in our nation's long term health and economic strength," he said in a statement emailed to __The Scientist__. "SfN sees the economic recovery package as a first step of what must be a long-term national commitment to prioritize and stabilize research funding." The House (with no support from Republicans) passed a version of the stimulus bill, which provided $3.5 billion in NIH funding, last week. Democrats and Republicans in the Congress will continue thrashing out the finer points of the bill, and the legislature is expected to have a version ready for President Barack Obama to sign by mid-February. Exactly how an NIH funding increase will be spent remains to be determined.
**__Related stories:__***linkurl:Bailing out life science;http://www.the-scientist.com/blog/display/55338/
[15th January 2009]*linkurl:$500 million NIH funds boost?;http://www.the-scientist.com/blog/display/55016/
[17th September 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development